The pharmaceutical sector shows a healthy growth. Bankruptcies is this sector are mainly those of pharmaceutical traders or distributors.
Nobili advises pharmaceutical companies relating to:
- bankruptcy of partner companies (pharmaceutical traders, distributors and others), which influence the activities and sustainability of pharmaceutical companies
- dispute resolution
- assessment of bankruptcy risks of pharmaceutical companies, pharmaceutical traders and others market players
- debtor-initiated bankruptcy proceedings
- representing the creditors in bankruptcy proceedings of pharmaceutical companies
- representing pharmaceutical companies in bankruptcy proceedings
- representation in criminal proceedings on the alleged bankruptcy fraud
- counteractions to fictitious bankruptcies